Send feedback

NR2F2 p.Pro16=

c.48C>T · rs1899165403 · VCV3051780

Likely benign No assertion criteria
Classification
Likely benign
ClinVar
Review
No assertion criteria ☆☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
very rare (popmax 0.00194%, sas)
Conditions
1
NR2F2-related disorder

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 1.3GERP -0.56, phastCons 1
Overall
CADD14.16PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00194% South Asian · 1/51,622 alleles
Filtering AF 7.6e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 2.1e-05%
Overall 0.000295% 4/1,354,786 alleles · very rare exomes 3/1,203,004 · genomes 1/151,782 · joint denominator
Ancestry group Frequency 1 in
South Asiangrpmax 0.00194% 51,622
European (non-Finnish) 0.000285% 351,247

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
NR2F2
Protein
p.Pro16=
Coding
c.48C>T
MANE Select
NM_021005
dbSNP
rs1899165403
Type
single nucleotide variant
Location
chr15:96332153 (GRCh38)
Gene constraint
LOEUF 0.197 · pLI 1.00 · ClinGen HI 0/3 (gnomAD)
Structure
AlphaFold pLDDT 77.94 · 1 PDB
Residue 16
the 'disordered' region
Full NR2F2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

NR2F2-related disorder

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nr2f2-p-pro16 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown